Skip to content

Based on my review of the GO-CAM model and relevant documents, I'll now provide a comprehensive assessment of the model gomodel:622aace900000443 titled "Fructose catabolic process (Mouse)".

Review of GO-CAM Model: Fructose catabolic process (Mouse) - gomodel:622aace900000443

Overview of the Model

This GO-CAM model describes the fructose catabolic process in mouse (NCBITaxon:10090). It represents a sequence of enzymatic reactions in the fructose metabolism pathway, specifically showing how fructose is broken down in the cytosol.

Model Structure and Components

The model consists of 5 activities interconnected with causal relationships:

  1. Ketohexokinase activity (Khk/MGI:MGI:1096353) - Converts fructose to fructose-1-phosphate
  2. Fructose-1-phosphate aldolase activity (Aldob/MGI:MGI:87995) - Splits fructose-1-phosphate into dihydroxyacetone phosphate and glyceraldehyde
  3. Aldehyde dehydrogenase (NAD+) activity (Aldh1a1/MGI:MGI:1353450) - Oxidizes glyceraldehyde to glycerate
  4. Aldehyde dehydrogenase (NAD+) activity (Aldh1a7/MGI:MGI:1347050) - Oxidizes glyceraldehyde to glycerate (parallel to Aldh1a1)
  5. Glycerate kinase activity (Glyctk/MGI:MGI:2444085) - Phosphorylates glycerate to 2-phosphoglycerate

All activities occur in the cytosol (GO:0005829) and are part of the fructose catabolic process (GO:0006001).

Causal Relationships in the Model

The model uses the "provides input for" (RO:0002413) relationship to connect activities in the appropriate sequence: - Khk → Aldob (fructose → fructose-1-phosphate) - Aldob → Aldh1a1 and Aldob → Aldh1a7 (fructose-1-phosphate → glyceraldehyde) - Aldh1a1 → Glyctk and Aldh1a7 → Glyctk (glyceraldehyde → glycerate)

Evidence and Annotations

The model is well-supported by evidence: - Most activities are supported by direct assay evidence (ECO:0000314) - Some activities are supported by mutant phenotype evidence (ECO:0000315) - References to relevant literature (e.g., PMID:29533924, PMID:4343087, PMID:29414685) - Evidence for protein localization in the cytosol

Quality Assessment

Strengths:

  1. Appropriate molecular functions: Each protein is annotated with a molecular function that accurately reflects its enzymatic activity.
  2. Correct causal relationships: The "provides input for" relation properly connects the activities in the metabolic pathway.
  3. Well-evidenced: All activities have appropriate evidence codes and literature citations.
  4. Correct cellular component: All activities are annotated to occur in the cytosol, which is accurate for this pathway.
  5. Pathway completeness: The model represents a complete pathway from fructose to 2-phosphoglycerate.

Potential Issues:

  1. Parallel aldehyde dehydrogenase activities: The model shows Aldh1a1 and Aldh1a7 performing the same function without clearly distinguishing their specific roles. While this may be biologically accurate (redundant enzymes), it would be helpful to provide evidence for why both are included.

  2. Missing metabolites: While GO-CAM doesn't require explicit representation of metabolites, it might be helpful to note the intermediate products in the annotations for clarity (e.g., dihydroxyacetone phosphate, which is the other product of Aldob activity, is not tracked in the pathway).

  3. Missing information on regulation: The model focuses on the core catalytic pathway but doesn't include any regulatory aspects that might control the pathway flux.

Literature Validation

The model is supported by cited literature, including: - PMID:29533924 which discusses ketohexokinase and aldolase B roles - PMID:4343087 which provides evidence for the fructose catabolic process - PMID:29414685 which supports glycerate kinase activity

The literature supports the sequence of events and enzyme activities depicted in the model.

Recommendations for Improvement

  1. Consider adding annotations to clarify functional differences between Aldh1a1 and Aldh1a7 if they exist (e.g., different kinetic properties, expression patterns, or substrate preferences).

  2. Add information about the fate of dihydroxyacetone phosphate (the other product of the aldolase reaction), which typically enters glycolysis.

  3. Consider adding regulatory aspects that control this pathway, such as feedback inhibition or transcriptional regulation of the enzymes involved.

  4. Add annotations about the physiological context where this pathway is most active (e.g., after fructose ingestion, in specific tissues like liver).

Conclusion

Overall, this is a well-constructed GO-CAM model that accurately represents the fructose catabolic process in mouse. It follows GO-CAM best practices by properly connecting molecular functions through causal relationships and providing appropriate evidence. The minor suggestions above would enhance the model's comprehensiveness but do not detract from its current quality and accuracy.